# OnCo record sonidegib (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix owl: <http://www.w3.org/2002/07/owl#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/sonidegib/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "sonidegib" ;
  schema:name "Sonidegib"@en ;
  schema:description "Sonidegib (Odomzo) is the second hedgehog inhibitor for locally advanced basal cell carcinoma, similar in effect and side effects to vismodegib."@en ;
  schema:url <https://onco.cc/drugs/sonidegib/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Sonidegib> ;
  owl:sameAs <http://www.wikidata.org/entity/Q22075856> ;
  schema:citation <https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=sonidegib> ;
  onco:status "approved" ;
  onco:tag "gap-fill" ;
  onco:modality "Small-molecule smoothened inhibitor" ;
  schema:alternateName "Odomzo" ;
  onco:approval "US 2015: Locally advanced BCC recurrent after surgery or radiation, or not candidates", "EU 2015: Same" ;
  onco:cancers <https://onco.cc/cancers/basal-cell-carcinoma/>, <https://onco.cc/cancers/medulloblastoma-shh/>, <https://onco.cc/cancers/locally-advanced-bcc/>, <https://onco.cc/cancers/skin-cancer/> ;
  onco:technologies <https://onco.cc/technologies/kinase-inhibitors/>, <https://onco.cc/technologies/hedgehog-inhibitors/> ;
  onco:targets <https://onco.cc/targets/smoothened/> ;
  onco:companies <https://onco.cc/companies/novartis/>, <https://onco.cc/companies/sun-pharma/> ;
  onco:terms <https://onco.cc/terms/hedgehog-inhibitor-tolerability/> .